PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,652,961 | -68.2% | 86,472 | -58.4% | 0.01% | -72.4% |
| Q2 2023 | $8,330,032 | +34.4% | 207,887 | +36.9% | 0.03% | +31.8% |
| Q1 2023 | $6,195,937 | -26.7% | 151,824 | +8.1% | 0.02% | -8.3% |
| Q4 2021 | $8,452,000 | +377.8% | 140,468 | +344.6% | 0.02% | +300.0% |
| Q3 2021 | $1,769,000 | -57.6% | 31,595 | -54.1% | 0.01% | -57.1% |
| Q2 2021 | $4,173,000 | -13.4% | 68,766 | 0.0% | 0.01% | -30.0% |
| Q1 2021 | $4,820,000 | +17.1% | 68,766 | -0.0% | 0.02% | +11.1% |
| Q4 2020 | $4,115,000 | +7.1% | 68,771 | -6.1% | 0.02% | -28.0% |
| Q2 2020 | $3,841,000 | – | 73,202 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,799,916 | $121,768,000 | 8.62% |
| Tamarack Advisers, LP | 625,000 | $27,044,000 | 8.22% |
| NEXTHERA CAPITAL LP | 149,086 | $6,484,000 | 5.40% |
| Spyglass Capital Management LLC | 379,609 | $16,509,000 | 5.22% |
| Gagnon Advisors, LLC | 107,412 | $4,671,000 | 2.67% |
| GAGNON SECURITIES LLC | 278,613 | $12,117,000 | 2.61% |
| Asymmetry Capital Management, L.P. | 84,735 | $3,685,000 | 2.00% |
| Rock Springs Capital Management LP | 1,250,000 | $54,363,000 | 1.97% |
| Lisanti Capital Growth, LLC | 118,620 | $5,159,000 | 1.68% |
| Elk Creek Partners, LLC | 500,069 | $21,748,000 | 1.62% |